185 related articles for article (PubMed ID: 36364889)
1. The Importance of Nutritional Aspects in the Assessment of Inflammation and Intestinal Barrier in Patients with Inflammatory Bowel Disease.
Kaczmarczyk O; Dąbek-Drobny A; Piątek-Guziewicz A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Szczyrk U; Strzałka M; Zagrodzki P; Zwolińska-Wcisło M
Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364889
[TBL] [Abstract][Full Text] [Related]
2. Association between fecal levels of Short-Chain Fatty Acids and serum Pro- and Anti-Inflammatory Cytokines in patients with Inflammatory Bowel Disease.
Kaczmarczyk O; Dąbek-Drobny A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Piątek-Guziewicz A; Wcisło K; Zagrodzki P; Zwolińska-Wcisło M
Folia Med Cracov; 2022 Jun; 62(1):43-55. PubMed ID: 36088592
[TBL] [Abstract][Full Text] [Related]
3. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
4. Association between Fecal Short-Chain Fatty Acid Levels, Diet, and Body Mass Index in Patients with Inflammatory Bowel Disease.
Dąbek-Drobny A; Kaczmarczyk O; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Piątek-Guziewicz A; Zagrodzki P; Zwolińska-Wcisło M
Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053106
[TBL] [Abstract][Full Text] [Related]
5. [Changes in tight junction protein expression and permeability of colon mucosa in rats with dextran sulfate sodium-induced inflammatory bowel disease].
Rao YX; Chen J; Chen LL; Gu WZ; Shu XL
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):976-81. PubMed ID: 23234790
[TBL] [Abstract][Full Text] [Related]
6. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease.
Heimerl S; Moehle C; Zahn A; Boettcher A; Stremmel W; Langmann T; Schmitz G
Biochim Biophys Acta; 2006 Mar; 1762(3):341-50. PubMed ID: 16439103
[TBL] [Abstract][Full Text] [Related]
7. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
8. Application of the Clustering Technique to Multiple Nutritional Factors Related to Inflammation and Disease Progression in Patients with Inflammatory Bowel Disease.
Dąbek-Drobny A; Kaczmarczyk O; Piątek-Guziewicz A; Woźniakiewicz M; Paśko P; Dobrowolska-Iwanek J; Woźniakiewicz A; Targosz A; Ptak-Belowska A; Zagrodzki P; Zwolińska-Wcisło M
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235613
[TBL] [Abstract][Full Text] [Related]
9. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion.
Jaworska K; Konop M; Bielinska K; Hutsch T; Dziekiewicz M; Banaszkiewicz A; Ufnal M
Exp Physiol; 2019 Aug; 104(8):1226-1236. PubMed ID: 31243807
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.
Vitale S; Strisciuglio C; Pisapia L; Miele E; Barba P; Vitale A; Cenni S; Bassi V; Maglio M; Del Pozzo G; Troncone R; Staiano A; Gianfrani C
PLoS One; 2017; 12(8):e0182313. PubMed ID: 28797042
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-1β on occludin mRNA expression in the duodenal and colonic mucosa of dogs with inflammatory bowel disease.
Ogawa M; Osada H; Hasegawa A; Ohno H; Yanuma N; Sasaki K; Shimoda M; Shirai J; Kondo H; Ohmori K
J Vet Intern Med; 2018 May; 32(3):1019-1025. PubMed ID: 29572935
[TBL] [Abstract][Full Text] [Related]
13. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
[TBL] [Abstract][Full Text] [Related]
15. Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species.
Zhang C; Li Q; Xing J; Yang Y; Zhu M; Lin L; Yu Y; Cai X; Wang X
Acta Biomater; 2024 Mar; 177():347-360. PubMed ID: 38373525
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis.
Saiz-Gonzalo G; Hanrahan N; Rossini V; Singh R; Ahern M; Kelleher M; Hill S; O'Sullivan R; Fanning A; Walsh PT; Hussey S; Shanahan F; Nally K; O'Driscoll CM; Melgar S
Front Immunol; 2021; 12():655960. PubMed ID: 34394073
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.
Ferrer-Picón E; Dotti I; Corraliza AM; Mayorgas A; Esteller M; Perales JC; Ricart E; Masamunt MC; Carrasco A; Tristán E; Esteve M; Salas A
Inflamm Bowel Dis; 2020 Jan; 26(1):43-55. PubMed ID: 31211831
[TBL] [Abstract][Full Text] [Related]
18. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
Marchelletta RR; Krishnan M; Spalinger MR; Placone TW; Alvarez R; Sayoc-Becerra A; Canale V; Shawki A; Park YS; Bernts LH; Myers S; Tremblay ML; Barrett KE; Krystofiak E; Kachar B; McGovern DP; Weber CR; Hanson EM; Eckmann L; McCole DF
J Clin Invest; 2021 Sep; 131(17):. PubMed ID: 34623320
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
